SGLT2 inhibitor oncology research expands as clinical proof remains uneven
A 346-publication analysis finds rapidly expanding research on SGLT2 inhibitors across cancer safety, antitumor mechanisms, real-world outcomes and cardio-oncology, but ...
Tag: cancer safety
POPULAR NEWS
-
Advanced Diffusion MRI Combined With Clinical Factors Shows Promise for Predicting Lymph Node Spread in Endometrial Cancer
-
Canine tumors closely model many adult human cancers, study finds
-
Chinese cannabis genomes reveal five regional genetic clusters
-
SGLT2 inhibitor oncology research expands as clinical proof remains uneven